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Decellularised skeletal muscles 
allow functional muscle 
regeneration by promoting host 
cell migration
Anna Urciuolo1,2,7, Luca Urbani  1,3,4, Silvia Perin  1, Panagiotis Maghsoudlou1, Federico 
Scottoni  1, Asllan Gjinovci1, Henry Collins-Hooper5, Stavros Loukogeorgakis1, Athanasios 
Tyraskis1, Silvia Torelli1, Elena Germinario6, Mario Enrique Alvarez Fallas1, Carla Julia-Vilella1, 
Simon Eaton  1, Bert Blaauw2,6, Ketan Patel5 & Paolo De Coppi1
Pathological conditions affecting skeletal muscle function may lead to irreversible volumetric muscle 
loss (VML). Therapeutic approaches involving acellular matrices represent an emerging and promising 
strategy to promote regeneration of skeletal muscle following injury. Here we investigated the 
ability of three different decellularised skeletal muscle scaffolds to support muscle regeneration in a 
xenogeneic immune-competent model of VML, in which the EDL muscle was surgically resected. All 
implanted acellular matrices, used to replace the resected muscles, were able to generate functional 
artificial muscles by promoting host myogenic cell migration and differentiation, as well as nervous 
fibres, vascular networks, and satellite cell (SC) homing. However, acellular tissue mainly composed 
of extracellular matrix (ECM) allowed better myofibre three-dimensional (3D) organization and the 
restoration of SC pool, when compared to scaffolds which also preserved muscular cytoskeletal 
structures. Finally, we showed that fibroblasts are indispensable to promote efficient migration and 
myogenesis by muscle stem cells across the scaffolds in vitro. This data strongly support the use of 
xenogeneic acellular muscles as device to treat VML conditions in absence of donor cell implementation, 
as well as in vitro model for studying cell interplay during myogenesis.
Skeletal muscle is the most abundant tissue in the human body and composed of muscle fibres, muscle stem cells, 
nerves, blood vessels, interstitial cells and ECM. Skeletal muscle regeneration is dependent on SCs, the resident 
stem cells of muscle located beneath the basal lamina of muscle fibres1–3. Despite having regenerative ability, 
skeletal muscle is unable to recover when the defect is too extensive (e.g. congenital malformations, traumatic 
injuries, surgical ablations or degenerative myopathies). As a consequence, skeletal muscle is not able to replace 
a VML and the result is a modification of the tissue architecture and composition accompanied by fibrosis and 
subsequent functional impairment or loss4. Available approaches to treat VML damages do not allow functional 
recovery of the damaged muscle5. Therefore, there is a great demand for developing new therapeutic strategy for 
VML.
Recent studies have shown the crucial role played by 3D environment and ECM on regulating stem cells iden-
tity and function6. Bioengineering approaches have attempted to combine natural/synthetic scaffolds with stem 
cells and growth factors for application in regenerative medicine7. Biomaterials have to replicate the properties 
of tissue-specific ECM, providing a 3D scaffold where stem cells can preserve their identity, adhere, proliferate, 
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differentiate and generate a cellular 3D structure resembling the tissue of interest. Moreover, it is also important 
that scaffolds have a good rate of biocompatibility and biodegradability in order to promote progressive replace-
ment with newly formed tissue without inducing any adverse inflammatory response, which could lead to scar 
tissue formation or scaffold rejection after in vivo implantation5. Despite improvement in biomaterials’ fabrication 
in recent years, there is an unmet need to develop scaffolds that respect all the above characteristics and support 
the development of functional tissues8,9. Generation of ECM scaffolds by means of decellularisation eliminates 
cellular and nuclear content, but maintains biological activity, mechanical integrity and 3D structure of the tissue 
from which the ECM is derived5. Commonly used methods of decellularisation include the use of chemical or 
enzymatic agents and physical methods such as sonication10. Acellular scaffolds are biocompatible and are not 
rejected after allogeneic or xenogeneic transplantation5. A number of studies have successfully obtained acellular 
scaffolds from organs such as trachea11, heart12, kidney13, pancreas14,15, lung16,17, liver18,19 and intestine20. Indeed, 
some decellularised organs are in clinical use21–23.
Acellular tissues –such as pig urinary bladder ECM, have been clinically used to treat VML conditions24, and 
only recently acellular skeletal muscle matrices have been tested for the same application in animal model of 
VML25–27. However, it still remains a matter of discussion whether the final in vivo outcome of acellular tissues 
can be influenced by the original tissue from which they are derived and by the specific protocol used for the 
decellularisation5,28–30. Here we investigate the ability of xenogeneic acellular muscles derived with three different 
perfusion protocols of decellularisation to be used as a device to promote functional muscle regeneration with-
out the implementation of donor cells. We showed that once implanted in a murine model of VML to replace a 
resected muscle, acellular scaffolds permit the development of an artificial muscle able to contract and generate 
force. Preservation of ECM components and 3D topology was the sufficient requirement to drive host cells toward 
scaffold repopulation, which allowed proper muscular stem cell maintenance, cell differentiation and homing, as 
well as functional tissue formation.
Methods
Animals. All the procedures performed on animals were in accordance with the Home Office and all the 
experimental protocols were approved by the UK Home Office, Project Licence PPL 70/7622. 250–350 g male or 
female Sprague Dawley rats were used for acellular muscle preparation. 3–4 months old C57BL/6J mice were used 
for in vivo scaffold implantation. C57BL/6J mice and transgenic GFP+ or transgenic C57BL/6-(ACTB-EGFP)/J 
mice were used a source of muscle stem cells (SC) and fibroblasts (FB). Mice were housed in individual cages in 
an environmentally controlled room (23 °C, 12 h light/12 h dark cycle) and provided food and water ad libitum.
Dissection of rat lower limb. 250–350 g rats were used as a source of muscle for decellularisation. Rats 
were killed by CO2 inhalation and death confirmed by onset of rigor mortis, the skin was carefully removed from 
the lower limb, abdomen, and lower back on the side of the desired limb (distally to the ankle does not need to 
be skinned, and may harm vasculature in doing so). In order to gain access to the iliac vessels, the abdomen was 
opened and bowels were resected. A 24 G cannula was inserted into the abdominal iliac artery and advanced 
distally. A suture was placed tightly around the femoral vessels to secure the cannula distal to the reflection of the 
abdominal wall and the major branches to the genitalia. On the medial aspect, half way between the hip and the 
knee, large cutaneous branches were also ligated. The leg was dissected from the rest of the body by splitting the 
pelvis at the pubic symphysis and the sacroiliac joint. Muscles of the lower back and the iliopsoas were dissected, 
to complete separation, sparing damage to the muscles of the lower limb.
Decellularisation protocols. The three protocols used, based on published studies29–33, were adapted to 
a perfusion condition and are summarized in Table 1. Perfusion of all solutions was achieved with a peristaltic 
pump (Rating Plate- iPump i150, iPump) at a flow rate of 1 ml/min. Optimal cycle number and conditions were 
determined by assessing DNA removal and preservation of tissue architecture.
Latrunculin B protocol (LatB): limbs were perfused with 50 nM latrunculin B (Sigma-Aldrich) in high-glucose 
Dulbecco’s modified Eagle’s medium (DMEM) (Gibco, Life Technologies, USA) for 2 hours at 37 °C. All of the 
following steps were performed at room temperature; washed with PBS for 30 minutes, 0.6 M potassium chloride 
(Sigma) for 2 hours, 1.0 M potassium iodide (Sigma) for 2 hours, de-ionized water overnight. The following day 
salt solutions were repeated, followed by perfusion with DNase-I (Sigma) in 1 M NaCl (Sigma) for 2 hours and 
overnight de-ionized water wash.
Each cycle of Detergent Enzymatic Treatment (DET) consisted of perfusion with de-ionised water (resistivity 
18.2 MΩ/cm) at 4 °C overnight, 4% sodium deoxycholate (Sigma) at room temperature (RT) for 4 hours, wash 
with PBS for 30 minutes, and 34 kU/ml DNase-I (Sigma) in 1 M NaCl (Sigma) at RT for 3 hours, and a final wash 
with de-ionized water for 48 hours.
Sodium Dodecyl Sulfate protocol (SDS): limbs were perfused with 0.25% SDS (Sigma) for 72 hours and 
washed in de-ionized water for 48 hours.
After each decellularisation treatment, muscles of interest were dissected and preserved at 4 °C, in PBS with 
1% Penicillin/Streptomycin (P/S - Gibco).
DNA quantification and agarose gel electrophoresis. DNA was extracted from tissues using DNA 
extraction kit (PureLink Genomic DNA MiniKit, Invitrogen) according to the manufacturer’s instructions. DNA 
content was estimated using a spectrophotometer (Tecan Infinity), measuring optical densities at 260 nm and 
280 nm.
Histology and Immunofluorescence. Samples were fixed in 10% neutral buffered formalin (pH 7.4), 
dehydrated through an alcohol series, embedded in paraffin and sectioned at a thickness of 5 μm. Tissue slides 
were stained with haematoxylin and eosin (H&E), Masson’s trichrome (MT), picrosirius red (PR) or elastin Van 
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Gieson (EVG; all Leica, Raymond A Lamb, BDH Chemicals Ltd) stains. For cryosections (10 μm), samples were 
fixed in PFA 4% in PBS for 10 mins at room temperature before being processed for the staining. Samples were 
analysed with an Olympus BX60 light microscope equipped with Olympus DP50 digital camera. Myofibre cross 
sectional area was calculated on 10x images by using ImageJ software; at least 500 myofibres were evaluated for 
each sample. For immunofluorescence analysis of acellular muscles, slides were de-paraffinized, antigen retrieval 
was performed using 10 mM sodium citrate buffer (pH 6.0) at 95 °C for 20 minutes, treated with 0.25% Triton 
X100 for 90 minutes at room temperature, and non-specific antibody binding was blocked with 5% horse serum 
in PBS for 1 hour at room temperature. Primary antibodies were added and left overnight at 4 °C; antibodies used 
were rabbit anti rat laminin (Abcam), at a dilution of 1:150; anti rat collagen IV (Abcam), at a dilution of 1:100; 
anti collagen I (Abcam), at a dilution of 1:100; anti dystrophin (Abcam), at a dilution of 1:200; anti α-dystroglycan 
(Millipore), at a dilution of 1:200; anti β-dystroglycan (Leica Biosystems), at a dilution of 1:50. Washes were per-
formed in PBS and an Alexa Fluor® 594 Goat Anti-Rabbit IgG (Invitrogen) was used as a secondary antibody at 
a dilution of 1:150. Washes were repeated and a mounting medium with DAPI (Vector Laboratories, USA) was 
used to secure the cover-slip. For immunofluorescence analysis of mouse EDL muscles, implants and in vitro 
repopulated scaffolds, samples were snap frozen and cross-sections or longitudinal sections of 10 μm were pre-
pared. To characterize primary cells, cells were firstly fixed in PFA at 4% in PBS, 5 minutes at room temperature. 
Cryo-sections or cells were then incubated for 1 hr at room temperature with 10% fetal bovine serum dissolved 
in PBS 0.1% Triton X100. When mouse antibodies were used for ex vivo samples, MOM kit (Vector laboratories) 
was used for the blocking step. Samples were then incubated with primary antibodies at 4 °C overnight. The fol-
lowing primary antibodies were used: mouse anti-Tubulin β3 (Clone Tuj1) (1:500, Biolegend); rabbit anti-laminin 
(1:150, Sigma); rabbit anti-von Willebrand factor (1:100, Abcam); rabbit anti-synaptophysin (1:100, Sigma); 
mouse anti-myosin heavy chain (1:100, R&D); mouse anti-embryonic myosin heavy chain (1:25, Hybridoma 
Bank); rabbit anti-ki67 (1:80, Abcam); mouse anti-pax7 (1:25, Hybridoma Bank); rabbit anti-α-smooth muscle 
actin (α-SMA, 1:100, Abcam); anti-desmin (1:100; Abcam); anti-vimentin (1:100; Abcam); rabbit anti-MyoD 
(1:50, Santa Cruz); anti-tcf4 (1:100; Millipore); mouse anti-MyoG (1:50, Abcam). After washings, samples were 
incubated with the appropriate secondary antibody for 1 hr at room temperature. Secondary antibodies used 
were anti-mouse (1:200, Invitrogen), anti-rabbit (1:200, Invitrogen), anti-rat (1:200, Sigma). For triple myosin 
and laminin co-staining, primary antibodies used were: BA-D5 (IgG 2b, 1:100, DSHB supernatant), SC71 (IgG1, 
1:100 DSHB, supernatant), BF-F3 (IgM, 1:100 DSHB, purified antibody), anti-laminin (1:100, Sigma-Aldrich), 
prepared in PBS-BSA 1%. Secondary antibodies were: DyLight 405 labeled goat anti mouse IgG, Fcγ 2b subclass 
specific (Jackson ImmunoResearch Europe), 1:200, Alexa Fluor 488 labeled goat anti mouse IgG, Fcγ 1 subclass 
specific (Jackson ImmunoResearch Europe) 1:200, Alexa Fluor 594 of Cy3 labeled goat anti mouse IgM, µ chain 
specific (Jackson ImmunoResearch Europe) 1:200, Alexa Fluor 647 labeled goat anti rabbit IgG (111-604-144, 
Jackson ImmunoResearch Europe) diluted in PBS-BSA 1%. Nuclei were stained with Hoechst 33258 (Sigma) 
dissolved in secondary antibody mix. When bungarotoxin staining was performed, tetramethylrhodamine conju-
gate α-bungarotoxin (Invitrogen) was added in the secondary antibody mix. Samples were analysed with a Leica 
DMI6000B fluorescence microscope with motorized stage or with a Leica SP5 confocal microscope.
Collagen and GAG quantification. Collagen was quantified using a QuickZyme Total Collagen Kit (2B 
Scientific, UK). Quantity of sulphated glycosaminoglycans (GAG) was measured using a Blyscan GAG Assay Kit 
(Biocolor, UK).
Scanning Electron Microscopy (SEM). Decellularised and fresh samples were fixed in 2.5% glutaraldehyde 
in 0.1 M phosphate buffer for 24 hours at 4 °C, followed by washes in 0.1 M phosphate buffer. The samples were 
then cut onto segments of approximately 1 cm in length and immersed in a cryoprotective solution of 25% sucrose, 
10% glycerol in 0.05 M phosphate buffer (pH 7.4) for 2 hours, then fast frozen and fractured in a nitrogen slush 
of approximately −160 °C, replaced in the cryoprotective solution at room temperature and allowed to thaw. The 
LatB (1 cycle) DET (3 cycles) SDS (1 cycle)
Time (h) T (°C) Reagent Time (h) T (°C) Reagent Time (h) T (°C) Reagent
2 37 50 nM Latrunculin B in high glucose DMEM ON 4 de-ionized water 72 RT 0.25% SDS
½ RT wash with PBS 4 RT 4% sodium deoxycholate 48 RT
wash with 
de-ionized water
2 RT 0.6 M potassium chloride ½ RT wash with PBS
2 RT 1.0 M potassium iodide 3 RT 34 kU/ml DNase in 1 M NaCl
ON RT de-ionized water 48 RT de-ionized water
2 RT 0.6 M potassium chloride
2 RT 1.0 M potassium iodide
2 RT 34 kU/ml DNase in 1 M NaCl
ON RT de-ionized water wash
Table 1. Summary of the three decellularisation protocols. LatB, Latrunculin B protocol; DET, Detergent 
Enzymatic Treatment; SDS, Sodium Dodecyl Sulfate protocol; ON, over night; T, temperature; RT, room 
temperature.
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samples were then washed in 0.1 M phosphate buffer (pH 7.4), fixed in 1% OsO4/0.1 M phosphate buffer (pH 7.3) 
at 3 °C for 1.5 hours, and washed again in 0.1 M phosphate buffer. Samples were then rinsed in deionized water 
and dehydrated using ethanol, critical point dried using CO2 and mounted on aluminium stubs, presenting the 
fractured surface of the samples. This surface was then coated with a thin layer of Au/Pd (approximately 2 nm) 
using a Gatan ion beam coater. Images were taken using a Jeol 7401 FEG scanning electron microscope.
For single fresh myofibres, anucleate and seeded ones, were fixed in 4% PFA for 10 minutes, dehydrated 
through 30, 50, 70, 80, 90, and 100% ethanol solutions (15 minutes for each step) and transferred to a critical 
point drier (Balzers CPD 030—using liquid carbon dioxide). Dried myofibres were transferred to SEM chucks 
using microforceps under a light microscope. Thereafter, myofibres were gold-coated using an Edwards S150B 
sputter-coater and examined using a FEI 600 F scanning electron microscope aided by analysis software for image 
collection.
Protein extraction and ELISA. ELISAs were performed for VEGF and IGF-I using Quantikine 
Immunoassay kits (RV00 and MG100 respectively) (R&D systems, USA).
The ELISA was performed according the manufacturer instructions. Optical density was measured using a 
Fluostar Optima microplate reader (BMG Labtech, Germany) at 450 nm wavelength with a correction wavelength 
of 570 nm.
Chick chorioallantoic membrane (CAM) angiogenic assay. Fertilized chicken eggs (Henry Stewart 
and Co., UK) were used to assess the angiogenic capabilities of the decellularised scaffolds. Eggs were incubated 
at 37 °C in controlled humidity; on day 3 oval windows of approximately 3 cm in diameter were made in the shell, 
thus exposing the embryo and CAM vessels. The window was then resealed with tape and replaced in the incu-
bator for a further 5 days. At this point, samples of decellularised scaffolds approximately 1.5 mm side length and 
square shaped were placed on the CAM between visible branches of vessels. Polyester sections soaked overnight 
either in a PBS solution or in PBS with 200 ng/mL VEGF were used as negative and positive controls respectively. 
On day 0, 5 and 7 after implantation the samples were photographed in ovo. The number of blood vessels con-
verging towards the placed tissues was counted blindly by assessors (n = 4), with the mean of the counts being 
considered. Moreover, cell infiltration and vessels formation into the scaffolds were also assess by staining cry-
osections with Alexa Fluor® 594 Phalloidin (Molecular Probes, USA) and nuclei with mounting medium with 
DAPI (Vector Laboratories, USA).
Extensor digitorum longus (EDL) ablation and scaffold implantation. Mice were anaesthetized 
using 0.5–3% isoflurane with oxygen via a nose cone. Induction of deep surgical anaesthesia was confirmed by 
absence of reaction to hind foot pinch. The surgical procedure underwent in aseptic conditions (skin preparation, 
sterilized instruments, gloves and drapes). It started with a skin incision along the tibia length then going lateral 
to the proximal edge of the Tibialis Anterior (TA) of the right leg. Subsequently, after the opening of the aponeu-
rosis, TA was gently moved to expose the EDL and the distal tendon of EDL was identified and transected. The 
EDL was then everted along its whole length and the first anastomosis, between one edge of the scaffold and the 
native EDL at half a centimetre from the proximal tendon, was made with a non-absorbable Prolene 7–0 suture. 
A second anastomosis, joining the other edge of the scaffold and distal tendon of native EDL, was made with 
a Prolene 7-0 suture. The native EDL was then resected between the anastomoses. Finally, the implanted EDL 
was repositioned in its original anatomic position and the skin wound was closed with Vicryl 6-0 suture. In the 
control EDL ablation’s mice (sham), the surgical procedure was the same, but no scaffolds were implanted; the 
native EDL was cut at the distal tendon and half a centimetre from the proximal tendon. Implanted scaffolds were 
derived from rat EDL acellular muscles, and were finely cut along the major axis to obtain scaffolds of the right 
size. No movement or space restriction were applied to animals after treatments.
Ex vivo force measurement. Two months after implantation, animals were killed by CO2 inhalation and 
cervical dislocation. Implants and EDL muscles of contralateral limbs were dissected and used to measure force 
production ex vivo. Force production of EDL muscles was determined as described previously34.
Primary cell preparation and culture into acellular muscles. Mice were sacrificed by CO2 inhala-
tion and cervical dislocation, according to UK legal guidelines. Single myofibres isolated from EDL muscles of 
three-month old wild-type C57BL/6J mice (wt) were the source of SCs and FBs for seeding into decellularised 
muscles. Single fibres were isolated from EDL muscles as previously described35. To release SCs from the myofi-
bres, single fibre preparation was then triturated 21 times using an 18 G needle (MicrolanceTM, US) mounted 
onto a 1 ml syringe, filtered through a 40 µm cell strainer and plated into a 60 × 20 mm culture-dish previously 
coated with 0.1% gelatine for 2 hours. SCs were cultured and expanded in proliferating medium (DMEM high 
glucose, 20% HS, 10% FBS, 1% P/S, 1% L-Glu, 1% Chicken Embryo Extract (CEE; Seralab, UK) and 0.5 µl/ml 
basic Fibroblast Growth Factor (bFGF; Sigma) at maximum for 1 passage, and then seeded into the scaffolds 
(expanded SCs were named MuSCs). FBs were isolated from mouse EDL harvested for single fibres preparation 
and not used for SC isolation (i.e. discarded tissue derived from the single fibre prep). FBs were expanded in 
DMEM, 20% FBS, 1% P/S, 1% L-Glu for a minimum of 3 passages before seeding into the scaffolds. Wild type- 
and GFP-MuSCs for seeding experiments on enucleated fibres were isolated from three-month old wild-type 
C57BL/6J mice (wt) and transgenic C57BL/6-(ACTB-EGFP)/J mice (GFP), with the expression of the enhanced 
GFP under the control of chicken beta actin promoter, as described in Pasut et al.36. Hindlimb muscles were dis-
sected and carefully minced. Enzymatic digestion was performed with collagenase-dispase solution (2.5 U/mL) 
at 37 °C for 12 min. This step was repeated until the tissue was almost entirely digested and appeared as a homog-
enous solution with no tissue chunks. An equal volume of 10% FBS-DMEM supplemented with pen strep was 
added and the cell suspension was filtered through a 70 μm filter. After centrifugation at 1800 rpm for 5 min, 
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the supernatant was discarded and cells resuspended in fresh SC growth medium (Ham’s F10 media, 20% FBS, 
1% Pens/Strep, 2.5 ng/mL bFGF). Cells were pre-plated in petri dishes coated with 0.01% collagen type I 
(Corning) for 1 hour and the supernatant transferred in freshly coated petri dishes. This step was repeated other 2 
times with pre-plating intervals of 24 hours before using the MuSCs for expansion and seeding. Acellular scaffold 
for cell seeding measured 8–10 mm length were obtained from decellularised rat hindlimb muscles. MuSCs, FBs 
or a mix of MuSCs and FBs (70:30) were suspended in a total amount of 5 µl of proliferating medium and injected 
into the scaffolds under a stereomicroscope and by using an insulin syringe. Cells were either seeded at a density 
of 1 × 106 cells per scaffold using multiple injections (for long term cultures) or 3 × 105 cells per scaffold with 
a single injection (for migration assay). Then seeded scaffolds were cultured in cell incubator for 7 or 14 days. 
During the first two days of culture, samples were cultured in DMED, 20% HS, 10% FBS, 1%P/S, 1% L-Glu, 1% 
CEE, 0.5 µl/ml bFGF. After 48 hours the medium was changed with DMEM, 2% HS, 1% P/S, 1% L-Glu until the 
end of the experiment. Single anucleate fibres were isolated from the EDL muscle of decellularised rat hindlimbs. 
Undamaged EDL muscle was dissected with both tendons intact and incubated with 0.1% collagenase type I in 
DMEM at 37 °C 5% CO2 for 2 hours. Using glass pipettes single anucleate fibres were collected and plated out in 
culture dishes containing PBS. Anucleate myofibres were gently washed in PBS 3 times before seeding or fixation. 
MuSCs were seeded on single anucleate myofibres in 12-multiwell plates without coating and monitored using 
phase-contrast microscope systems that harbour controlled-environment chambers maintained at 37 °C, supple-
mented with 5% CO2 as previously described37. Single freshly isolated myofibres from wt mouse-EDL muscles 
were used as control. Myofibres were cultured in wells containing DMEM supplemented with 10% FBS and 0.5% 
CEE. Time-lapse video was taken at rate of one frame every 15 minutes for periods of up to 24 hours using an 
x10 objective. Time-lapse experiments were performed with GFP-MuSCs. In a separate analysis, high power 
time-lapse microscopy using an x100 objective was carried out, enabling the visualization of cell surface blebbing 
on single MuSCs. For such analysis, cells were cultured for 24–48 hours, then selected, and subsequently filmed 
at a rate of one frame per 2 seconds. All image analysis was carried out using ImageJ (version 1.4.3). MuSCs were 
individually manually tracked using the plugin MTrackJ, and bleb dynamics were quantified using ImageJ. Bleb 
number was quantified manually on SEM images of cells using Adobe Photoshop version CS2, only SEM images 
of whole cells were used for quantification. MuSCs differentiation profiles following differing culture conditions 
were manually assessed using quantification of live images through the Zeiss Axioscope and Axiovision digital 
camera system. Only cells adherent to the myofibres were considered for the quantification. Statistical analysis 
was performed using Student’s t test unless indicated otherwise with a significance level of p < 0.05.
MTT analysis. MTT cell proliferation assay was performed on seeded scaffolds to determine the vitality 
and proliferation of seeded cells after 7 days of culture using Vybrant® MTT cell proliferation assay kit (Life 
Technologies; Thermo Fisher scientific). Images of the whole scaffolds were taken with a stereomicroscope 
(Leica) and then samples were dissolved each in 500 μl of propan-2-olo acid solution overnight in agitation and 
at room temperature. For MTT quantification, scaffolds were removed and the absorbance of the isopropanol was 
recorded at 555 nm with a plate reader (Infinite F200, Tecan).
Statistical analysis. For immunofluorescence and immunohistochemical analyses, at least 8 random 
high-power field areas were considered per each condition analysed. We expressed data as means ± s.e.m. or, 
where indicated, as means ± s.d. We determined statistical significance by one-way ANOVA and Tukey’s multiple 
comparison test or Kruskal-Wallis and Dunn’s multiple comparison test. A p value of less than 0.05 was consid-
ered statistically significant. Where not differently specified, n refers to the number of animal/scaffolds analysed.
Data availability. The datasets generated during and/or analysed during the current study are available from 
the corresponding author on reasonable request.
Results
Intravascular decellularisation of rat hindlimb allowed generation of acellular skeletal muscle 
tissue. To allow homogenous and good level of decellularisation of thick skeletal muscle tissue from rat hind 
limb, constant perfusion of decellularising solutions through the muscle vessels was performed26. Acellular scaf-
folds were created using three different decellularisation protocols: LatB, DET and SDS (Fig. 1a,b). For LatB, one 
cycle was sufficient to remove the cellular compartment and preserve the ECM structure, whilst three cycles for 
DET and 72 hours of SDS perfusion were needed to obtain the same level of decellularisation (Supplementary 
Fig. 1). Treated hind limbs displayed different macroscopic appearance (Fig. 1d). Compared to freshly isolated 
muscles, DNA content was significantly reduced by all decellularisation protocols (Fig. 1c), a finding confirmed 
by H&E staining and scanning electron microscopy (SEM). However, both H&E and SEM analyses clearly 
showed that, among the 3 protocols, acellular muscles displayed different histological characteristics. General 
tissue structure including myofibres was largely preserved in LatB- and DET-generated samples. In contrast, 
myofibre content was greatly depleted by SDS treatment leaving mainly the ECM (Fig. 1d).
Native skeletal muscle components were differently preserved among the three decellulari-
sation protocols. To better understand how the three decellularisation protocols affected key proteins of 
skeletal muscle homeostasis, a series of specific histological staining were performed on cross sections of freshly 
isolated rat skeletal muscle and LatB-, DET- and SDS-acellular muscles. Masson’s trichrome (MT), picrosirius 
red (PR) and elastin Van Gieson (EVG) were used to evaluate the nuclei, cytoplasm and ECM maintenance upon 
decellularisation (Fig. 2a). All the staining confirmed absence of nuclei in decellularised tissues. MT and PR 
showed that collagen was still present in all acellular muscles. EVG staining showed the maintenance of elastin 
in all the derived-acellular muscles (Fig. 2a). All decellularised muscles contained significantly less collagen and 
GAG than freshly isolated muscles (Fig. 2b,c). Examination of specific ECM components revealed the presence 
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of collagen I, collagen IV and laminin (Fig. 2d, and Supplementary Fig. 2). In contrast, specific sarcolemma pro-
teins were differentially preserved depending on the method used for decellularisation. In particular, dystrophin 
was almost completely lost in all the scaffolds with some fibers still positively stained in LatB- acellular muscles 
(Supplementary Fig. 2). Instead α- and β-dystroglycans were almost completely lost in DET-decellularised mus-
cles, but partially preserved in those generated by LatB- and SDS (Supplementary Fig. 2).
Acellular scaffolds promoted angiogenesis in vivo and preserved chemokines. We next deter-
mined whether acellular muscles would support in vivo angiogenesis using an established CAM assay (Fig. 3a–c). 
The number of vessels converging towards the decellularised samples DET and SDS was identical to the positive 
control and higher than the negative control (Fig. 3a,b), with evidence of cell and vessel invasion into the scaffolds 
(Fig. 3c). ELISA analysis confirmed the presence of relevant chemokines in the decellularised muscles. In par-
ticular, vascular endothelial growth factor (VEGF) was still detectable in DET- and SDS-acellular muscles, albeit 
reduced when compared to freshly isolate muscles (Fig. 3d). In contrast, LatB-scaffolds showed complete loss of 
VEGF (Fig. 3d) and a lower angiogenic effect in the CAM assay. Moreover, all the three decellularised procedures 
preserved the insulin-like growth factor (IGF-1), despite its amount was reduced when compared to freshly iso-
lated muscles (Fig. 3e).
Acellular scaffolds restore muscle function in a murine model of VML. Support of in vivo mus-
cle regeneration by the acellular muscles was tested using a mouse model of VML37, where the EDL muscles 
were resected and substituted with either LatB-, DET- or SDS-acellular scaffolds (Fig. 4a,b). All animals survived 
Figure 1. Decellularisation protocols. (a) Diagram showing the process used to prepare rat hind limbs for 
decellularisation. The femoral artery is cannulated and the hind limb dissected; decellularised reagents where 
delivered through the vessel tree by using a pump directly connected to the cannula. Three different decellularisation 
methods were performed, and called LatB, DET and SDS. (b) Diagram showing steps used to perform LatB, DET and 
SDS decellularisation. (c) Quantification of DNA content in freshly isolated rat skeletal muscle and LatB-, DET- and 
SDS-decellularised muscles. Data are shown as mean ± s.e.m of three independent replicates; **P < 0.01, one-way 
ANOVA and Tukey’s multiple comparison test; no significant differences were observed among the decellularised 
samples; n = 6–10, each group. (d) Macroscopic and microscopic (H&E and scanning electron microscopy, SEM) 
evaluation of fresh rat muscles and LatB-, DET- and SDS-decellularised samples. For H&E analysis, cross-sections 
were analysed. Scale bars, macroscopic: 1 cm; H&E: 100 µm; SEM: 10 µm.
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Figure 2. Characterization of decellularised skeletal muscle ECM. (a) Masson’s trichrome (MT), picrosirius red 
(PR) and elastin Van Gieson (EVG) staining of cross-sections from positive control tissues (+ve CTRL), freshly 
isolated rat skeletal muscle (fresh), LatB-, DET- and SDS-acellular muscles. Scale bar, 10 µm. (b) Collagen 
quantification of freshly isolated rat skeletal muscle (fresh), LatB-, DET- and SDS-acellular muscles. (c) GAGs 
quantification of freshly isolated rat skeletal muscle (fresh), LatB-, DET- and SDS-acellular muscles. Data are 
shown as mean ± s.e.m of three independent replicates; **P < 0.01; one-way ANOVA and Tukey’s multiple 
comparison test; no significant differences were observed among the decellularised samples; n = 6–10, each 
group. (d) Representative images of immunofluorescence analysis for collagen IV (Col IV) and laminin (all 
red) in cross-sections derived from freshly isolated rat skeletal muscle (fresh), LatB-, DET- and SDS-acellular 
muscles. Nuclei were stained with dapi (blue). Scale bar: 100 µm.
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surgery without complication. Two months after implantation the macroscopic appearance of the site of implan-
tation was free from scar tissue or inflammation (Fig. 4c). As expected30, no new tissue development or muscle 
regeneration were found between the two edges of the resected EDL in negative control animals (Fig. 4dB). In 
contrast, in all animals transplanted with decellularised scaffolds, the site of implantation showed tissue regener-
ation (Fig. 4dC,e). Artificial muscles were of similar size to contralateral untreated EDL muscles and had compa-
rable weights (Fig. 4e,f). To investigate whether the regenerated tissues were functional, ex-vivo force generation 
analysis was performed. Interestingly, all the artificial muscles were able to contract and generate force with no 
significant differences observed between the three groups, despite showing partial restoration of muscle strength 
when compared to contralateral untreated EDL (Fig. 4g,h). Immunofluorescence analysis for the neural marker 
Tuj1 and bungarotoxin confirmed the presence of the nervous system in the implanted scaffolds two months 
Figure 3. Angiogenetic properties and chemokine maintenance of decellularised skeletal muscles. (a) 
Representative images of CAM assay performed for filter embedded with VEGF (positive control, CTRL+), 
and LatB-, DET- and SDS-acellular muscles. Scale bar: 2 cm. (b) Quantification of vessel converged toward 
filter loaded with PBS (negative control, CTRL-) or VEGF (positive control, CTRL+) and LatB-, DET- and 
SDS-acellular muscles at the moment of the implantation (0), 5 or 7 days after implantation. The number of 
vessels significantly increased 7 days after implantation (0) in CTRL+, DET and SDS samples. Data are shown 
as mean ± s.e.m of three independent replicates; no significant differences were observed among the three 
scaffolds and positive control; n = 4 independent experiment per each group. (c) Representative images of DET-
acellular muscle cryosections 7 days after egg implantation, and stained with phalloidin (red) and dapi (blue). 
Autofluorescence of the scaffold (green) is also showed in panel A. Panel B, higher magnification of phalloidin 
(red) and dapi (blue). Scale bar: 25 µm. (d) Quantification of VEGF content in freshly isolated rat skeletal 
muscle and LatB-, DET- and SDS-decellularised muscles. Data are shown as mean ± s.e.m of three independent 
replicates; *P < 0.05; **P < 0.01, each decellularised sample compared to fresh muscles; one-way ANOVA 
and Tukey’s multiple comparison test; no significant differences were observed among the decellularised 
samples; n = 6–12, each group. (e) Quantification of IGF-1 content in freshly isolated skeletal rat muscles and 
LatB-, DET- and SDS-decellularised muscles. Data are shown as mean ± s.e.m of three independent replicates; 
**P < 0.01, each decellularised sample compared to fresh muscles; n.s., not significant; one-way ANOVA and 
Tukey’s multiple comparison test; no significant differences were observed among the decellularised samples; 
n = 4–8, each group.
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Figure 4. Implanted decellularised skeletal muscles allow functional muscle regeneration in a mouse model of VML. 
(a) Schematic diagram showing the surgical strategy used to generate VML model and implantation of acellular 
scaffolds. (b) Representative images showing the surgical procedure used for scaffold implantation. EDL muscle 
was exposed (A) and a first anastomosis was performed between the proximal edge of EDL muscle and the scaffold 
(B). The second anastomosis was carried out to the distal tendon of the EDL, then the scaffold length adapted to 
the implant size and the native EDL muscle resected between the two anastomosis (C). No-absorbable stitches are 
blue. Implant was relocated in the original anatomic position (D) and skin sutured (E). (c) Representative images 
showing macroscopic appearance of untreated contralateral (A) and implanted (B) mouse hindlimb 2 months 
after implantation. Arrow points at the proximal stitch used to anchor the scaffold to the native EDL muscle (blue). 
(d) Representative images showing macroscopic appearance of contralateral untreated EDL muscle (A), negative 
control muscle (B) and implanted scaffold (C) 2 months after implantation and after tibialis anterior dissection. (e) 
Representative images showing macroscopic appearance of contralateral untreated (UNTD, left) and LatB-, DET- 
and SDS-implanted EDL muscles (right) 2 months after implantation. (f) Mean weight of contralateral untreated 
EDL muscles (UNTD) and LatB-, DET- or SDS-implanted muscles two months after implantation. Data are shown 
as mean ± s.e.m.; n = 8-7, each group. No significant differences were observed among the groups. (g) Ex vivo force 
measurement of untreated EDL muscles, and LatB-, DET- and SDS-implants two months after implantation. Data 
are shown as mean ± s.e.m.; n = 6, each group. No significant differences were observed among the groups. (h) 
Ratio of the maximal force generated ex-vivo from regenerated implants (LatB, DET and SDS) and contralateral 
untreated EDL muscles two months after implantation. Data are shown as mean ± s.e.m.; n = 6, each group. No 
significant differences were observed among the groups. (i) Representative confocal images of cross-sections from 
contralateral untreated EDL muscles, and LatB-, DET- and SDS-implanted scaffolds stained with bungarotoxin (BTX 
- red) and synaptophysin (SYP - green) two months after implantation. Nuclei were stained with dapi (blue) and 
phase contrast (PhC) is shown to highlight staining localization (scale bar: 10 µm). (j) Percentage of neuromuscular 
junctions in untreated and implanted scaffolds calculated as percentage of SYP/BTX double-positive cells. **P < 0.01; 
***P < 0.001 each decellularised sample compared to untreated muscles.
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Figure 5. Decellularised skeletal muscles induce muscle regeneration in a mouse model of VML. (a) H&E 
staining of cross-sections from contralateral untreated EDL (UNTD) and the middle region of LatB-, DET- and 
SDS-implanted scaffolds two months after implantation. Scale bar: 250 µm. (b) Masson’s Trichrome staining of 
cross-sections from UNTD muscles and the middle region of LatB-, DET- and SDS-implanted scaffolds two 
months after implantation. Scale bar: 250 µm. H&E staining of cross-sections from UNTD muscles and LatB-, 
DET- and SDS-implanted scaffolds two months after implantation. Cross-sections showed centrally nucleated 
fibres, connective tissue and myofibres of variable size into the implanted scaffold. Scale bar, 50 µm. (c) 
Representative images of immunofluorescence analysis for laminin (green) in cross-sections from contralateral 
untreated EDL muscles, and (d) LatB-, DET- and SDS-implanted scaffolds, two months after implantation. 
Nuclei were stained with dapi (blue). Scale bar, 100 µm. Bottom line: higher magnifications to show centrally 
nucleated fibres (CNF). Scale bar, 50 µm. (e) Quantification of the number of fibres per field and respective 
contribution of CNF and non-CNF in UNTD muscles and implanted scaffolds, using images of laminin 
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after implantation (Supplementary Fig. 3), while bungarotoxin and synaptophysin co-staining demonstrated 
the presence of functional neuromuscular junctions in all implants (Fig. 4i). The percentage of synaptophysin/
bungarotoxin double-positive NMJ were comparable in all implanted scaffolds, but significantly lower than 
untreated contralateral muscles (Fig. 4j). Moreover, histological examination revealed the presence of skeletal 
muscle tissue in the artificial muscle, and interestingly in the middle and distal regions of the implants (Fig. 5a–d, 
Supplementary Figs 4–5). Confirmation of muscle regeneration was given by the presence of centrally nucleated 
myofibres in the implants, which also showed correct deposition of laminin (Fig. 5c,d). The percentage of cen-
trally nucleated fibres was comparable among the 3 implants, with no significant difference determined: LatB 
28.76 ± 24.43, DET 19.71 ± 12.33 and SDS 19.38 ± 15.32 (n = 4–6) (Fig. 5e). Interestingly and in contrast to LatB- 
and DET-implants, mean muscular tissue area was reduced in SDS-implants, when compared to contralateral 
untreated muscles (Fig. 5d). Connective tissue deposition was evident mostly in the junction between scaffold 
and native muscle, as well as in the distal portion of the implanted scaffolds (Supplementary Fig. 5). In addition, 
all the artificial muscles showed clear evidence of vascularization throughout the length of the grafts, with a num-
ber of vWF+ vessels comparable to contralateral untreated muscles (Fig. 5g,h).
To investigate if regenerated skeletal muscles properly occurred into artificial muscles, morphometric analysis 
of fibre cross-sectional area (CSA) was performed. All decellularised scaffolds showed small or large fibres, com-
pared to contralateral untreated muscles (Fig. 5i–k and Supplementary Fig. 6). No difference was observed among 
LatB-, DET- or SDS-implants regarding the mean CSA of small myofibres, however, LatB-muscles showed an 
higher mean CSA in bigger myofibres, when compared to DET and SDS-implants (Fig. 5j,k and Supplementary 
Table 2). Characterization of muscle fibres through myosin heavy chain profiling revealed that LatB-implants 
supported the development of fibre type 2A at the expenses of fibre type 2B, compared to DET and SDS scaffolds 
(Fig. 6). LatB-muscles also displayed a significant reduction in the percentage of fibre type 2B, when compared to 
contralateral untreated muscles (Fig. 6a–c). When myofibre dimension was quantified considering the major axis 
of the fibres, all the implanted scaffolds showed lower mean length of the major axis compared to contralateral 
untreated EDL muscles. Nevertheless, myofibres of SDS-implants were significantly “longer” when compared 
LatB- and DET-implants (Fig. 6d).
With the aim to understand if decellularised scaffold could also promote SCs homing, the number of sublam-
inal cells expressing the transcription factor paired box protein 7 (Pax7) in respect to the total myofiber number 
was quantified in LatB-, DET- and SDS-implants and compared to untreated contralateral EDL muscles. The pres-
ence of a pool of Pax7+ cells under the basal lamina of myofibres was evident in all implanted scaffolds. However, 
LatB- and DET- implants showed a lower number of Pax7+ cells compared to UNTD muscles and SDS-implants 
(Fig. 6e,f).
Muscle stem cells can migrate along decellularised single myofibres. Since muscle stem cells 
(MuSCs) are the major player of muscle regeneration, it is reasonable to speculate that MuSCs can migrate across 
the scaffolds and be involved in the artificial muscle regeneration. It is also have been showed that MuSCs present 
on single myofibres migrate and proliferate in vitro35,38. Therefore, we firstly evaluated the ability of MuSCs to 
recognise acellular myofibres, migrate and proliferate on their surface in a bi-dimensional in vitro cell culture 
system. To reach this aim, single fibres isolated from LatB and SDS acellular muscles were seeded with wild-type 
or GFP+ mouse MuSCs in vitro (Fig. 7a). DET was omitted as showing similar structure characteristics to LatB. 
Single fibres from LatB-acellular muscles were easier to isolated than from to SDS scaffolds, which produced 
very few intact anucleate fibres (Fig. 7b). Both LatB and SDS single fibres showed distinct appearance com-
pared to those from normal freshly isolated ones, with notches evidencing the previous location of myonuclei 
(Fig. 7c). Interestingly, murine MuSCs were able to adhere to anucleate myofibres and migrate along their surface 
(Fig. 7d,f). Migration speed and mechanism (i.e. blebbing)38 were evaluated and compared to resident activated 
cells in mouse freshly isolated myofibres38. Cellular migration speed was reduced in both the anucleate myofibre 
preparations, when compared to activated MuSCs on freshly isolated myofibres (Fig. 7e). Nevertheless, analysis 
of movement of cells along the length of the fibres indicated comparable diffusive movement among the 3 condi-
tions, showing similar cellular displacement along the fibre in the first 700 minutes of migration (Supplementary 
Fig. 7). This was associated to comparable blebbing dynamics (extension, stabilisation and retraction), lifespan, 
immunofluorescence staining. (f) Quantification of muscle area per field in UNTD muscles and LatB-, DET- 
and SDS-implanted scaffolds two months after implantation. *P < 0.05 compared to UNTD; one-way ANOVA 
and Tukey’s multiple comparison test; n = 4–6, each group. (g) Representative immunofluorescence images of 
cross-sections from LatB-, DET- and SDS-implanted scaffolds stained with for von Willebrand factor (vWF, 
red) two months after implantation. Nuclei were stained with dapi (blue) and phase contrast (PhC) is shown 
to highlight staining localization and tissue structure (scale bar: 10 µm). (h) Quantification of the number of 
vWF+ vessels in implanted scaffolds (n = 4–6). (i) Percentage of myofibres with cross-sectional area (CSA) less 
the 500 µm2, between 500 and 1000 µm2, between 1000 and 2000 µm2, between 2000 and 3000 µm2, between 
3000 and 3500 µm2, or more than 3500 µm2 in UNTD muscles, LatB-, DET- and SDS-implanted scaffolds two 
months after implantation. n = 4–6, each group. (j) Mean cross-sectional area (CSA) of myofibres showing CSA 
less than 500 µm2 in UNTD muscles, LatB-, DET- and SDS-implanted scaffolds two months after implantation. 
Data are shown as mean ± s.e.m. **P < 0.01, compared to contralateral untreated muscles; data were analysed 
by using Kruskal-Wallis and Dunn’s multiple comparison test; n = 4–6, each group. (k) Mean cross-sectional 
area (CSA) of myofibres showing CSA more than 3500 µm2 in EDL contralateral untreated muscles (UNTD), 
LatB-, DET- and SDS-implanted scaffolds two months after implantation. Data are shown as mean ± s.e.m. 
Statistical analysis was performed by using Kruskal-Wallis and Dunn’s multiple comparison test and reported in 
Supplementary Table 1.
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Figure 6. Characterization of myofibre type and length of LatB-, DET- and SDS-implanted scaffolds. (a) 
Representative z-stack confocal images of longitudinal sections from contralateral untreated EDL muscle 
(UNTD) and LatB-, DET- and SDS-implanted scaffolds two months after implantation. Laminin (magenta) and 
myosins recognising type 2 A (green), type 2B (red), type 2AB (green and red) and type 1 (blue) myofibres were 
identified by immunofluorescence. Scale bar: 25 µm. (b) Representative z-stack confocal images of longitudinal 
and cross-sectional sections from contralateral untreated EDL muscle (UNTD) and LatB-, DET- and SDS-
implanted scaffolds two months after implantation. Type 2 A (green), type 2B (red), type 2AB (green and red), 
type 1 (blue), and type X (black) myofibres were identified together with laminin (magenta) staining. Scale bar, 
100 µm. (c) Quantification of type 2 A, 2B, 2AB, type 1 and type X myofibres in contralateral untreated EDL 
muscle (UNTD) and LatB-, DET- and SDS-implanted scaffolds two months after implantation. Data are shown 
as mean ± s.e.m. Statistical analysis was performed by using two-way ANOVA and Tukey’s multiple comparison 
test and reported in Supplementary Table 2. (d) Quantification of the mean length of myofibre major axis in 
contralateral untreated EDL muscle (UNTD) and LatB, DET- and SDS-implanted scaffolds two months after 
implantation. **P < 0.01 compared to UNTD; §P < 0.01 compared to SDS; one-way ANOVA and Tukey’s 
multiple comparison test; n = 4–6, each group. (e) Representative confocal images of sections from contralateral 
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shape and size between fresh and anucleate seeded myofibres (data not shown). Next to their ability in activating 
cell migration with blebbing formation, LatB- and SDS-anucleate myofibres also supported MuSCs proliferation, 
reproducing what normally occurs in freshly isolated single fibres. Moreover, SDS-myofibres showed a higher 
ability to preserve cells expressing the key transcription factor Pax7, compared to LatB-anucleate myofibres 
(Fig. 7g,h).
Migration of SCs in a decellularised skeletal muscle require fibroblasts. Despite MuSCs showed 
the ability to be cultured on single acellular fibres in vitro, we also evaluated their potential when cultured into 
3D decellularised muscle. Indeed, the more complex and constrained culture environment that MuSCs found 
when cultivated into acellular matrix, in respect to the single fibre culture system, may influence MuSC behav-
iour. Moreover, this in vitro model better mimicked the hypothetical in vivo condition, in which myogenic cells 
had to migrate across the implanted scaffolds for its repopulation. We decided to perform the following studies 
only on SDS-scaffold based on the similar regenerative potential observed among of the three scaffolds in vivo 
and the results obtained in the single anucleated fibre experiments in vitro. Firstly, murine SCs were isolated and 
amplified as MuSCs only for 1 passage in proliferating medium, characterized before seeding into the scaffolds. 
As expected, stripped SCs grew in culture as colonies and, when dissociated as single cells, MuSCs were able to 
be expanded in proliferating supporting medium and to differentiate into myotubes in culture (Supplementary 
Fig. 8a). After two passages of expansion and just before seeding, MuSCs were characterized in terms of prolifer-
ation and expression of myogenic markers (Supplementary Fig. 8b,c). The majority of MuSCs was proliferating 
and showed high expression of Pax7 (71%) and the myogenic regulatory factor MyoD (75%). In contrast, only 
a small percentage of cells expressed the early differentiating transcription factor Myogenin (MyoG, 14%) and 
the late differentiating protein embryonic myosin heavy chain (eMyHC, 9%; Supplementary Fig. 8c). In line with 
published work39, the majority of Pax7+ cells co-expressed MyoD (89%; Supplementary Fig. 8c). In agreement 
with this fact and the low percentage of early differentiating cells (i.e. MyoG+), the majority of MyoD+ cells was 
still expressing Pax7 (80%, Supplementary Fig. 8c). Moreover, almost all the cells expressing Pax7 or MyoG were 
in a proliferating phase (93% and 85%, respectively; Supplementary Fig. 8c). Altogether, these results indicate that 
the MuSC cultures, that were used to repopulate the scaffolds, are constituted of proliferating myogenic cells that 
retained expression of the stem cell marker Pax7. Having confirmed their myogenic potential, we tested the ability 
of MuSCs to repopulate the decellularised SDS-scaffold.
Interestingly, when MuSCs were injected into SDS- scaffolds and cultured in vitro for 7 days, a number of 
multinucleated myotubes expressing eMyHC were present at the injection site (Fig. 8a). These results indicated 
the ability of MuSCs to maintain the myogenic commitment and to undergo late muscle differentiation when cul-
tivate into 3D acellular scaffolds (Fig. 8a). However, overall scaffold repopulation with MuSCs was unsuccessful, 
since cells were found only at the area of injection (Fig. 8). This was clearly different from the in vivo finding in 
which host cells repopulated the all implanted scaffolds and it was probably related to the fact that multiple cells 
orchestrate organization of scaffold colonization after transplantation. In particular, muscle fibroblasts (FBs) are 
known to play a key role in ECM remodelling and to regulate SC proliferation and differentiation during muscle 
regeneration28,31,40,41. Based on this established concept, we hypothesized that fibroblasts could be responsible of 
the efficient regeneration observed in vivo and they could therefore improve scaffold repopulation and myogene-
sis when seeded into the acellular muscles together with MuSCs in vitro. FBs were therefore isolated from mouse 
EDL and expanded in culture before being used for seeding experiments. Primary FBs displayed typical morphol-
ogy and expressed vimentin and the nuclear factor Tcf4, but were negative for α-SMA expression (Supplementary 
Fig. 8d)35,42. Moreover, the majority of the cells were proliferating and did not expressed desmin, confirming the 
absence of contaminating myogenic cells into the FBs primary culture (Supplementary Fig. 8d).
To elucidate the influence of FBs on scaffold repopulation and myogenesis, a comparison of SDS scaffolds 
seeded with MuSCs or FBs or the combination of both MuSCs and FBs was performed after 7 days of culture 
(Fig. 8). Firstly, scaffold repopulation and cell migration from the site of injection were evaluated. FBs migrated 
readily within the scaffold and clearly affected the colonization of myogenic cells, which was strongly improved 
when MuSCs were seeded together with FBs. This was highlighted both by immunofluorescence (Fig. 8a,c) and 
identification of viable cells with MTT (Fig. 8d). Furthermore, differentiated myogenic cells (eMyHC-positive) 
were completely absent when FBs were seeded alone (Fig. 8a). Since FBs have been shown also to improve ter-
minal differentiation of newly formed fibres in vivo42–44, SDS scaffolds seeded with MuSCs or MuSCs-FBs were 
analyzed in terms of cross-sectional area (CSA) of multinucleated myotubes. As observed in vivo42–44, myogenic 
cells infiltrating into acellular scaffolds generated large myotubes in presence of FBs (Supplementary Fig. 9). The 
maturation of myotubes after 7 days in 3D culture was further demonstrated by the spontaneous twitching of 
myotubes present in SDS scaffolds seeded with MuSCs and FBs (Supplementary Movie 1).
Starting from these data, SDS scaffolds cultivated with MuSCs-FBs were further analysed for the presence of 
FBs, myogenesis and cell proliferation (Fig. 9). Seven days after culture, proliferating stem cells (ki67+Pax7+), 
committed myogenic cells, differentiated cells and myotubes (MyoG+) were found in SDS scaffolds, as showed 
by immunofluorescence analysis (Fig. 9a). Moreover, a population of Tcf4+ cells was also detected (21.8 ± 24% 
on total number of cells), some of which were proliferating (ki67+; Fig. 9a). The percentage of Pax7+ stem cells 
calculated on the total number of Tcf4− cells was 67.5 ± 23.3% (Fig. 9b). Scanning electron microscopy (SEM) 
untreated EDL muscle (UNTD) and LatB-, DET- and SDS-implanted scaffolds two months after implantation; 
staining for Pax7 (red - arrows) and laminin (green) and dapi (blue). Scale bar: 10 µm. (f) Quantification 
of Pax7+ cells in sublaminar position per myofibre in contralateral untreated EDL muscle (UNTD) and 
LatB, DET- and SDS-implanted scaffolds two months after implantation. Data are shown as mean ± s.e.m. 
***P < 0.001; **P < 0.01 compared to UNTD.
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Figure 7. Isolation and seeding of anucleate myofibres. (a) Single myofibres were isolated from fresh or 
decellularised rat EDL digested in collagenase I and collected under the microscope. (b) Yield of fibres per 
EDL, ***p < 0.001 vs Fresh, t-test. (c) Scanning electron microscopy of single fresh and anucleate myofibres 
from LatB- and SDS-decellularised EDL. Scale bar: first row 100 µm, second row 10 µm, third row 1 µm. (d) 
Murine MuSCs were seeded on single myofibres and fresh EDL fibres were cultured to activate resident MuSCs. 
(e) Cellular migration speed along single fibres measured 24 hours post-seeding; ***p < 0.001, ANOVA. (f) 
Representative images of GFP+ MuSCs migrating on LatB-scaffold derived anucleate fibres, scale bar: 10 µm. 
(g) Immunofluorescence for MyoD and Pax7 of wild-type MuSCs seeded on LatB and SDS anucleate myofibres 
after 72 hours of culture, scale bar: 100 µm. (h) Subpopulations of cells according to positivity for Pax7 and 
MyoD after 72 hours of culture with statistical analysis showing significance in respect to control (CTRL). 
*p < 0.05; **p < 0.01; ***p < 0.001 vs CTRL, t-test.
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analysis revealed complex network of interaction created between seeded cells and ECM and confirmed the pres-
ence of multinucleated myotubes embedded into the ECM of the scaffolds. Furthermore, cells appeared to align 
following the 3D organization of the ECM that formed a track generated with the decellularisation process that 
removed the majority of the pre-existing myofibres (Fig. 9c). To understand if decellularised scaffolds could also 
allow cell maintenance and support myogenesis for a longer period of culture, MuSCs co-seeded with FBs were 
grown in culture for 14 days (i.e. 2 days in proliferating media and 12 days in differentiating media). Interestingly, 
prolonged cell culture increased scaffold repopulation, permitted the maintenance of myotube and the Pax7+ cell 
population and preserved cell proliferation (Fig. 9d,e).
Discussion
VML represents still a clinical challenge and a definitive therapeutic solution has not yet been described. ECM 
components have been shown to play important role for promoting proper muscle regeneration and maintenance 
of SC stemness35,39,45,46. Decellularised matrices have the advantage of mimic architecture and organization of 
the native tissue and ideally presents the same biochemical composition, cell homing activation, biomechanical 
Figure 8. In vitro colonization of acellular scaffold using MuSCs and FBs. (a) Representative scan images of 
scaffold cross-sections seeded with MuSCs, FBs or MuSCs-FBs analysed by immunofluorescence analysis using 
anti-laminin (red) and anti-MyHC antibodies (green). Laminin was used to identify the entire cross section of 
the scaffolds. Nuclei were stained with Hoechst (blue). Scale bar: 500 μm. (b) Representative images acquired 
at stereomicroscope of MTT assay performed on unseeded or seeded scaffolds cultured with MuSCs, FBs or 
MuSCs-FBs. Scale bar: 1 mm. (c) Analysis of cell distribution in scaffold cross-sections seeded with MuSCs or 
MuSCs-FBs. *P < 0.05, one-way ANOVA and Tukey’s multiple comparison test; (d) Availability assay by MTT 
quantification. Data are shown as mean ± s.e.m. of six independent replicates. **P < 0.01; one-way ANOVA and 
Tukey’s multiple comparison test.
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and angiogenic properties of the tissue of interest31,40,41. Since the decellularisation procedure can alter the ECM, 
compromising its biochemical, biomechanical and structural properties, we optimized and compared three dif-
ferent protocols previously published on non-perfusion decellularisation for skeletal muscles29–33. We obtained 
three different homogenous decellularised skeletal muscles that showed comparable ECM components, but with 
different preservation of myofibre structure. LatB and DET-scaffolds maintained fine myofibre structure and 
could therefore described as enucleated instead of decellularised. Myofibres were largely absent following SDS 
treatment, which was mainly constituted by ECM. For reasons of clarity and direct comparison to other pub-
lished studies, scaffolds were still referred to as decellularised. Although the importance of ECM components 
has been demonstrated for in vivo scaffold repopulation by host cells5, the possible role of sarcolemmal pro-
teins and other components remains under debate. Despite the similarity with LatB-acellular muscles discussed 
above, DET-scaffolds showed almost complete absence of all the proteins located at the sarcolemma analysed. 
Interestingly, SDS-scaffolds partially preserved α- and β-dystroglycans, suggesting that sarcolemmal proteins 
could still be retained, probably through the connection to the ECM components.
Figure 9. Characterization of SDS scaffolds repopulated with MuSCs and FBs. (a) Immunofluorescence 
analysis of scaffold cross-sections seeded with MuSCs-FBs and cultured for one week by using Pax7 (magenta) 
and ki67 (green), or MyoG (red) and laminin (green), or Tcf4 (magenta) and ki67 (green). Nuclei were stained 
with Hoechst (blue). Scale bar: 100 μm. (b) Percentage of Pax7-positive and negative cells in co-cultured 
scaffolds after one week. (c) SEM analysis showing cell-ECM interaction in SDS scaffolds seeded with MuSCs-
FBs and cultured for one week. The insert show a single cell spreading its projections to the ECM. Scale bar: 
20 μm left panel; 10 μm middle and right panel. (d) Immunofluorescence analysis of scaffold cross-sections 
seeded with MuSCs-FBs and cultured for two weeks by laminin (red) and eMyHC (green). Nuclei were stained 
with Hoechst (blue). Scale bar: 50 μm. (e) Immunofluorescence analysis of scaffold cross-sections seeded with 
MuSCs-FBs and cultured for two weeks by Pax7 (red) and ki67 (green). Nuclei were stained with Hoechst 
(blue). Scale bar: 50 μm.
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Besides preservation of proteins and tissue architecture, efficient regeneration depends also on the ability 
of the graft to maintain specific chemokines known to be important in promoting angiogenesis and cellular 
migration while reducing inflammation to facilitate repopulation and local regeneration5,27. Among those, we 
focused on VEGF and IGF, which are respectively involved in promoting vessel formation and in supporting 
muscle growth, regeneration and maintenance47. LatB-, DET- and SDS-acellular muscles all showed maintenance 
of IGF1. Differently, only DET- and SDS-acellular muscles showed the maintenance of VEGF, while LatB scaf-
folds did not preserve a detectable amount of VEGF, showing reduce ability to attract vessels in CAM assay. This 
suggest that other mechanisms rather than VEGF could be involved in the promotion of vessel formation by 
LatB-scaffolds upon implantation.
Despite the varying degrees of muscle micro-architecture preservation in our scaffolds, we found extensive 
muscle regeneration two months after implantation in all implanted scaffolds. We observed correct deposition 
of matrix around newly formed myofibres, formation of functional myofibres, together with blood vessels, inva-
sion of nerves and functional NMJ, with no differences among the three different scaffolds. Importantly, all the 
implanted scaffolds allowed the homing of SCs –i.e Pax7+ cells in sublaminal position. Functional recovery of 
the treated muscles was confirmed by the ability of artificial muscles to contract and generate force in ex vivo 
physiological activity tests. Despite SDS-regenerated muscles showed reduced muscle area when compared to 
the other implants, we did not observe functional differences in the recovery of the transplanted muscle. All 
artificial muscles displayed altered myofibre CSA and myofibre major axis length together with increased pres-
ence of connective tissue, when compared to untreated contralateral EDL muscles. These features, together with 
the reduced number of functional NMJ observed in the artificial muscles, could explain the reduction in force 
production observed in the implants, when compared to untreated contralateral muscles. At deeper investiga-
tion, in vivo muscle remodelling activated by LatB-, DET- and SDS-implants gave rise to muscles with different 
characteristics, which could have implications on large VML repair. SDS-muscles displayed a myofibre type ratio 
similar to untreated EDL muscles together with bigger myofibre major axis length, when compared to LatB- and 
DET-implants. In addition, the SDS-regenerated muscles were the only implants in which the number of SCs was 
found to be comparable to untreated contralateral EDL muscles. Different hypotheses could explain the contrast-
ing results obtained with LatB-, SDS- and DET-scaffolds. For example, it is possible that the presence of the cyto-
plasm of myofibres in LatB- and DET-scaffolds caused a mechanical obstacle during scaffold repopulation, which 
did not allow the right orientation of the newly formed myofibres and/or myofibre type profile, as well as correct 
restoration of SC pool. Based on these findings, we can conclude that myofibre preservation in decellularized 
skeletal muscles do not improve host cell response. Instead, the use of a harsher decellularization that removes 
myofibre content but maintaining the ECM 3D organization and composition –i.e. SDS-scaffolds, was found to 
be more efficient in promoting muscle regeneration and cell homing in vivo. In SDS-implants, the presence of 
the remodelling ECM can allow the formation of better aligned myofibres with right specification, together with 
proper SC pool preservation, which can potentially permit further cycles of muscle regeneration.
Different studies demonstrate that upon implantation, acellular tissues can be invaded by host cells and be 
remodelled, allowing host progenitor and stem cells to populate the new matrix5,25,27,31,40,48. Muscle-derived scaf-
folds obtained with protocols similar to those described in this study have shown to activate an immune modu-
latory host response that leads to scaffold degradation and new tissue formation. According with this and based 
on the histology observed in artificial muscles, we can hypothesize that this is also happening in our implanted 
scaffolds which have been remodeled and replaced by new tissue. How the enucleated myofibers are degraded 
–i.e. in LatB- and DET-implants, and the possible preservation of donor extracellular matrix components remain 
matters of further investigation. The degradation of the ECM-derived scaffolds has shown to have a positive 
influence on tissue regeneration since it induces the release of bioactive molecules that modulate macrophage 
polarization phenotype and activate local stem cells49–51. Despite further analysis need to be done to clarify the 
role of different cell types in the development of artificial muscles in vivo, the presence of SCs in implanted mus-
cles and the in vitro results demonstrated the involvement of MuSCs in the promotion of muscle regeneration 
observed in LatB-, DET- and SDS-artificial muscles. The importance of MuSCs in promoting tissue regeneration, 
vascularization and innervation of decellularised matrix implants revealed in our study have been suggested also 
from others5,25,27,31,33,40,48,52,53. According to in vivo results, our in vitro studies demonstrated the ability of acellular 
muscles to support MuSCs adhesion, proliferation, maintenance of Pax7 expression and differentiation. Despite 
MuSCs were able to migrate along decellularised isolated fibers, the more complex 3D environment required the 
presence of fibroblasts to achieve MuSC colonization and myogenesis into acellular muscles. Fibroblasts have a 
crucial role on secreting key components of the extracellular matrix, such as collagen VI and fibronectin, which 
are essential for SC maintenance35,46. Moreover, fibroblasts also directly influence the dynamics of MuSCs during 
regeneration and their absence lead to the inability of MuSCs to proliferate and efficiently regenerate the site of 
injury following cardiotoxin injection43. Such cross-talk between MuSCs and FBs was also evident in our analysis, 
since the two cell population do not undergo to a selection process under the specific culture conditions used, 
respecting approximatively the ratio used at the seeding. We can therefore speculate that the process by which 
our scaffolds promote in vivo muscle progenitor migration involved various pathways, but it maybe ultimately 
guided by fibroblasts.
Xenogeneic scaffolds derived from other tissues rather than skeletal muscle coupled with physical therapy 
have been shown to partially ameliorate force outcome of a cohort of patients affected by VML24. A recent study 
demonstrate that acellular matrix derived from small-intestine submucosa and urinary bladder matrix failed to 
recover in a porcine model of VML54. Therefore, it still remains a matter of discussion whether the use of tissue 
specific acellular muscles could improve the overall clinical outcome of treated patients. Among limitations in 
applying acellular skeletal muscles scaffolds in clinic, decellularisation procedure represents per se a challenging 
aspect for this tissue, since its great thickness represent a limiting step for obtaining good quality and reproducible 
scaffolds. Indeed, studies involving the use of acellular skeletal muscle only refer to their application in animal 
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models of VML. The majority of these studies used acellular muscles obtained by immersion protocols of decel-
lularisation and often in combination with cell therapy25,40,41,48,52,55–57. In particular, a recent study reported the 
ability of MuSCs in combination with muscle resident cells (MRCs) pre-seeded in acellular skeletal muscles to 
restore structure and function of muscles with acute and chronic VML injuries, which can be further improved by 
a regimen of exercise25. Despite the VML model used in our study differed from what reported above25, the added 
value of our work resides in the demonstration that acellular skeletal muscles obtain with our perfusion protocols 
allow the development of functional artificial muscles without the implementation of donor cells in severe VML 
model and also in a xenogeneic model. Considering the well-known limitations of cell therapy approaches, the 
consequence that this aspect can have for future clinical application of such scaffolds as device to treat VML is 
extremely important. Devices based on decellularised muscles do not require expensive and potentially dangerous 
autologous cell harvesting and expansion and therefore facilitate clinical translation of VML treatment. Moreover, 
the ability of acellular muscles not coupled with cell therapy to promote functional muscle regeneration has been 
poorly investigated. Zhang et al. reported absence of innervation and scattered muscle formation upon implanta-
tion of acellular muscles derived by perfusion methods of decellularisation26. Differently, we demonstrated with 
three different perfusion methods of decellularisation that acellular muscles can promote extensive myogenesis, 
as well as functional innervation. Moreover, we show here for the first time, by comparing different method of 
decellularization, that myofibre preservation in decellularized skeletal muscles may be irrelevant for regeneration, 
which appears to be mainly driven by ECM 3D organization and composition. In conclusion, we strongly believe 
that these findings are of great importance in the design of new therapies based on tissue-engineering technology 
and may influence the design of scaffolds for engineering skeletal muscle tissue, as well as in the future application 
of decellularised muscles as in vitro models to investigate cell interplay during myogenesis.
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